Core Viewpoint - Binance co-founder Changpeng Zhao (CZ) has strongly denied a Financial Times report suggesting that his venture capital firm YZi Labs is planning to raise outside capital, labeling the article as "fake news" and asserting that YZi Labs has never pitched to external investors [1][3][6] Group 1: YZi Labs Overview - YZi Labs, rebranded from Binance Labs earlier this year, is a $10 billion venture capital firm managing CZ's estimated $80 billion fortune along with funds from Yi He and early Binance executives [4] - The firm has investments in over 250 projects, including notable names like Polygon, Aptos, and CertiK, and has expanded its focus beyond cryptocurrency to include AI and biotech [4] Group 2: Response to Financial Times Report - The Financial Times article suggested that YZi Labs was evolving from a family office into an externally facing investment vehicle, indicating potential expansion plans due to regulatory discussions and investor interest [2][6] - CZ refuted the claims made by the Financial Times, emphasizing that there has been no communication regarding fundraising efforts and criticized the media for conflating different issues related to his legal situation [3][5]

Funding News - Archetype, a crypto VC firm, secures over $100 million for its third fund [1] - The fund is backed by global institutions [1]

Core Insights - The investment landscape in Shanghai is undergoing a significant transformation, characterized by the deep integration of capital, industry, and talent, leading to a collaborative value creation methodology that is taking root and generating new possibilities [1] Group 1 - The shift in the venture capital environment in Shanghai indicates a move towards a more integrated approach, combining various elements to foster innovation and growth [1] - The emphasis on collaboration among capital, industry, and talent suggests a strategic pivot that could enhance the effectiveness of investment initiatives [1] - The concept of value co-creation is becoming a foundational principle in the Shanghai venture capital scene, indicating a shift from traditional investment models to more dynamic and interactive frameworks [1]

Group 1: Advisory Group Formation - An advisory group is being formed by members of New York City's business community to guide mayoral candidate Zohran Mamdani if he wins the election in November [1] - The group includes notable figures such as Andrew Milgram from Marblegate Asset Management and Kevin Ryan from AlleyCorp [1][7] - OneNYC, an independent expenditure committee, is organizing the council with input from various sources, including Partnership for New York City CEO Kathy Wylde [2] Group 2: Mamdani's Campaign and Policies - Mamdani, a democratic socialist, has pledged to freeze rents, provide free child care, and open government-run grocery stores, but his plans to raise taxes on corporations and the wealthy have raised concerns among business leaders [3] - His criticism of Israel has also caused unease within the business community [3] Group 3: Business Community Engagement - Wylde emphasized the importance of Mamdani's outreach to the business community, stating that he will need their support to address the city's challenges if elected [4] - Yasser Salem from OneNYC mentioned the goal of assembling a panel of experts across various sectors to develop policies that reinforce New York City's status as a global business leader [4] Group 4: Campaign Finance and Polling - Under campaign finance rules, the advisory group cannot coordinate directly with Mamdani, who currently holds a double-digit lead in polling against his opponents [5] Group 5: Marblegate Asset Management - Marblegate, led by Milgram, is the largest owner of medallions in New York City, having acquired thousands of them after their value collapsed due to the rise of ride-sharing companies [6] - The firm specializes in distressed and special situations and also operates a loan-servicing business and a taxi clubhouse for drivers [6] Group 6: Tech Community Engagement - Ryan from AlleyCorp has been active in organizing meetings between Mamdani and members of the tech community as part of a strategy to address their concerns [8] - Mamdani has engaged in discussions with prominent business leaders, including Jamie Dimon and Brad Karp, to foster relationships and mitigate concerns about his rhetoric [8] Group 7: Fundraising and Future Strategies - OneNYC has raised $179,000 for pro-Mamdani campaigns and has nearly $1 million in commitments [9] - The advisory council is expected to develop strategies for public-private partnerships and talent recruitment for Mamdani's potential administration [9]

Archetype raises over $100 million for latest crypto venture fund https://t.co/AQEN0fX03X ...

Tim Chen, solo VC at his firm Essence VC, just closed his fourth fund, a fresh $41 million, without even trying. https://t.co/1k7BIWobTD ...

StrictlyVC is back at TechCrunch Disrupt in October, bringing together the insiders who shape the venture capital landscape, this time with a sharper focus on the market’s biggest challenge: liquidity. In an era of extended exit timelines, slowed distributions, and increasingly selective LPs, the conversations behind closed doors matter more than ever. Working with Cendana Capital, which has backed 80+ funds in its 15-year history, we are launching a new off-the-record LP track that offers an unfiltered lo ...

Albion Technology & General VCT PLCLEI Code: 213800TKJUY376H3KN1623 September 2025 Albion Technology & General VCT PLC (the "Company") Half-yearly Financial Report for the six months to 30 June 2025 Results announcementThe Company's Directors attach the Company's Half-yearly Financial Report for the six months to 30 June 2025. A summary of the information includes: Loss in the period of 0.58 pence per share (0.8% on opening net asset value) (30 June 2024: return of 4.99 pence per share).Net asset value of 7 ...

Core Viewpoint - Victory Square Technologies Inc. has announced its intention to commence a Normal Course Issuer Bid (NCIB) to purchase up to 5,000,000 common shares, representing approximately 5% of its issued and outstanding shares, as a strategy to enhance shareholder value [1][2][3]. Group 1: NCIB Details - The NCIB will commence on September 24, 2025, and will remain in effect until September 23, 2026, or until the maximum number of shares has been purchased [2]. - Purchases will be made at prevailing market prices through the facilities of the CSE and/or other permitted trading systems [2]. - BMO Nesbitt Burns Inc. has been appointed to coordinate and facilitate the purchases under the NCIB, with all purchased shares to be cancelled [3]. Group 2: Strategic Capital and Growth - In 2022, the company raised strategic capital to fund infrastructure for Hydreight Technology Inc. and VSDH, avoiding shareholder dilution while strengthening its core IP [4]. - A lender exercised an option to convert capital into Hydreight shares at a 20% discount, resulting in the transfer of 607,057 shares to settle $1,600,000 in debt [5][6]. - Following this settlement, the company holds approximately 25,326,124 Hydreight shares valued at around $122.3 million, with no outstanding debt [6]. Group 3: 2025 Priorities and Future Outlook - Management set three clear goals for 2025, with the initiation of the NCIB being the next logical step in returning value to shareholders [7]. - The CEO emphasized that the strategic capital raised in 2022 helped scale businesses like Hydreight and VSDH, which now represent significant value for the company [7]. - The current market capitalization is believed to not reflect the value of the company's portfolio, which includes various companies targeting large addressable markets [9]. Group 4: Upcoming Investor Engagement - Victory Square will host an Investor Webinar on October 2, 2025, to provide a detailed NAV breakdown of the company's portfolio and highlight upcoming catalysts [10].

Company Overview & Strategy - The firm is a life sciences venture fund with over 50 years of history, investing in biotechnologies, medical devices, industrial biotech, and digital medicine [1][2] - The company's mission is to advance medicine and bring expertise to the industrial biotechnology field [2] - The fund strategy sits at the intersection of life sciences and technology, bridging traditional life science approaches with digital medicine [4] Portfolio & Partnerships - The firm has connections with about 100 active portfolio companies [2] - The company emphasizes the benefits of connecting portfolio companies with Nvidia, streamlining processes and improving analysis speed [3] - The NVIDIA VC Alliance program connects the firm with other VCs across the ecosystem and industry, providing exposure to the tech side [3][4] Competitive Advantage & Value Proposition - The company provides portfolio companies with exclusive access to compute resources, offering a competitive advantage [6] - The firm offers the ability to tweak compute requirements as needed, which is valuable for startups building massive data assets [7] - The company enables portfolio companies to scale data processing quickly, accelerating the path to value inflection points [8][9]